NCCTG N0879 (Alliance): A randomized phase II trial of carboplatin, paclitaxel, bevacizumab, with or without everolimus for therapy of metastatic malignant melanoma
      Google Scholar   
Citation:
Eur J Cancer vol 51 (S672) abstr 3324
Meeting Instance:
ECC 2015
Year:
2015
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
2649  
Program:
OGC
Primary Committee:
Experimental
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                   
Networks:
LAPS-MN026, SANFORD   
Study
NCCTG-N0879
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: